by Clare Gerrard | Mar 16, 2023
Vaccination Update March 2023: COVID Infections, such as pneumonia or COVID, can seriously impact on the symptoms experienced, quality of life and overall health of all patients with Neuroendocrine Cancer – particularly those with DIPNECH and/or a Lung Primary,...
by Clare Gerrard | Oct 17, 2022
INCA Supported a Study on the Impact of COVID-19 on NET Management, Now Published in the Journal of Neuroendocrinology An abstract of a study with the active involvement of the global neuroendocrine tumor (NET) community was published in the Journal of...
by Clare Gerrard | Oct 4, 2022
Delighted to launch the Cancer52 video showcasing the amazing work of Cancer52 members in response to the Covid-19 pandemic. The Showcase Video highlights the innovation and tenacity of our members in the face of the extraordinary challenges of the past couple of...
by Leanne Talbot | Jul 15, 2021
All Neuroendocrine Cancer patients globally are invited to share their experiences and perspectives on how treatment decisions have been modified during the COVID-19 pandemic for them via a specially designed survey. The survey is available in English, French, Italian...
by Leanne Talbot | May 27, 2021
NET CONNECT is a group of both established and next-generation international experts in the field of neuroendocrine tumours (NET). The Steering Committee and Members aim to collaborate in scientific activities, share best practices and discuss the latest scientific...